Our Pricing

How Phenergan Syrup Works for Allergies & Sleep

Published on: June 03, 2026

Understanding phenergan syrup for allergies UK options helps you make informed treatment decisions. Phenergan syrup contains promethazine hydrochloride, a first-generation antihistamine that blocks histamine receptors to relieve allergic symptoms whilst causing drowsiness that can aid sleep. At Cured Pharmacy, our UK clinical team can assess whether Phenergan or modern non-drowsy alternatives better suit your needs.

What Is Phenergan Syrup and How Does It Work?

Phenergan syrup contains promethazine hydrochloride, a sedating antihistamine that has been licensed in the UK for over 60 years. It works by blocking histamine H1 receptors in the body, preventing histamine from triggering allergic symptoms like itching, sneezing, and watery eyes [1]. Unlike modern antihistamines, promethazine readily crosses the blood-brain barrier, which explains both its sedative effects and its effectiveness for nausea.

The syrup formulation typically contains 5mg of promethazine hydrochloride per 5ml, making it particularly suitable for children who cannot swallow tablets. The MHRA licenses Phenergan syrup for allergic conditions including hay fever, urticaria, and allergic reactions to insect bites, as well as short-term insomnia in adults [2]. The sedative properties develop within 20 minutes of administration and can last 4-6 hours, though drowsiness may persist longer in some patients.

Promethazine belongs to the phenothiazine class of medications, which means it also has mild anticholinergic effects. These contribute to its effectiveness for motion sickness and nausea but also explain side effects like dry mouth and blurred vision that some patients experience [1].

Phenergan Syrup for Allergies: Clinical Effectiveness

For allergic rhinitis and hay fever, Phenergan syrup provides effective symptom relief, particularly for sneezing, itching, and rhinorrhoea. Clinical studies demonstrate that promethazine significantly reduces histamine-induced wheal and flare responses compared to placebo, with effects lasting up to 12 hours after a single dose [3]. However, the sedation it causes means most UK prescribers now reserve it for situations where modern antihistamines have proven insufficient.

The sedative properties that once made Phenergan a first-line choice now limit its daytime use. Patients taking promethazine should avoid driving, operating machinery, or consuming alcohol, as the MHRA specifically warns about impaired psychomotor performance [2]. For children attending school or adults working, these restrictions make non-drowsy alternatives like fexofenadine or cetirizine more practical for routine allergy management.

When Phenergan Syrup Remains Clinically Appropriate

UK prescribers may recommend Phenergan syrup when allergic symptoms disrupt sleep, when other antihistamines have failed to control severe itching, or for acute allergic reactions requiring rapid sedation. The syrup format also offers advantages for children who resist tablet medications, though it should only be used in children over 2 years of age due to respiratory depression risks in younger infants [2].

Using Phenergan Syrup as a Sleep Aid

Promethazine's sedative effects make Phenergan syrup a licensed short-term treatment for insomnia in adults, though the MHRA emphasises it should not be used for more than 7 consecutive nights without medical review [2]. The typical adult dose for sleep is 20-25mg (20-25ml of syrup) taken 30-60 minutes before bedtime. Unlike benzodiazepines, promethazine does not carry the same dependency risks, but tolerance to its sedative effects can develop with regular use.

Clinical guidance from NICE suggests that sedating antihistamines should not be first-line treatments for chronic insomnia, as they do not address underlying sleep disorders and may cause next-day impairment [4]. The residual drowsiness that many patients experience the following morning can affect driving ability and workplace performance, particularly in older adults who metabolise promethazine more slowly.

For children, Phenergan syrup is occasionally prescribed for short-term sleep disturbances, but only under careful medical supervision and never in children under 2 years. The Royal College of Paediatrics and Child Health advises that behavioural sleep interventions should be attempted before medication, and that promethazine should be reserved for exceptional circumstances where sleep deprivation poses significant health risks [2].

Phenergan Syrup Dosage and Administration

For allergic conditions in adults and children over 10 years, the typical dose is 10-20mg (10-20ml) taken 2-3 times daily. Children aged 5-10 years usually receive 10mg twice daily, whilst children aged 2-5 years receive 5mg twice daily. These doses should not be exceeded without explicit medical advice, as promethazine has a narrow therapeutic window and overdose can cause severe central nervous system depression [2].

The syrup should be measured using the provided oral syringe or medicine spoon to ensure accurate dosing. Taking Phenergan with food can reduce gastrointestinal side effects, though this does not significantly affect absorption. Patients should avoid taking double doses if they miss a scheduled administration, as this increases the risk of excessive sedation and anticholinergic effects.

Duration of treatment matters significantly. For allergic conditions, Phenergan should ideally be used intermittently rather than continuously, as tolerance develops and effectiveness diminishes with prolonged use. If symptoms require daily antihistamine treatment for more than 2 weeks, UK prescribers typically recommend switching to a non-sedating alternative like fexofenadine or cetirizine for better long-term symptom control without sedation [3].

Special Populations and Dosing Adjustments

Elderly patients require lower doses due to increased sensitivity to anticholinergic effects and slower drug clearance. The MHRA advises particular caution in patients over 65, as promethazine can increase falls risk and may worsen cognitive function. Patients with hepatic impairment also require dose reduction, as promethazine undergoes extensive liver metabolism [2].

Modern Alternatives to Phenergan Syrup for Allergies

Second-generation antihistamines like fexofenadine represent a significant advancement over promethazine for routine allergy management. These medications selectively block peripheral H1 receptors without crossing the blood-brain barrier in significant amounts, providing effective symptom relief without sedation [5]. At Cured Pharmacy, fexofenadine tablets start from £6.99 and offer once-daily dosing with no driving restrictions, making them more suitable for most working adults and students.

For nasal symptoms specifically, corticosteroid nasal sprays like beclometasone or mometasone often provide superior symptom control compared to oral antihistamines. Clinical trials demonstrate that nasal corticosteroids reduce all four cardinal symptoms of allergic rhinitis (sneezing, itching, rhinorrhoea, and congestion) more effectively than oral antihistamines, particularly for nasal blockage which antihistamines address poorly [6]. These sprays work locally with minimal systemic absorption, avoiding the sedation and anticholinergic effects associated with Phenergan.

For patients with both nasal and eye symptoms, combination approaches work best. Pairing a non-drowsy oral antihistamine with a topical nasal spray addresses symptoms through complementary mechanisms. Some patients benefit from Optilast eye drops for ocular symptoms alongside systemic treatment, providing targeted relief without additional sedation.

Safety Considerations and Side Effects

The most common side effects of Phenergan syrup include drowsiness, dizziness, dry mouth, blurred vision, and urinary retention. These anticholinergic effects occur more frequently in elderly patients and can be particularly problematic for those with pre-existing conditions like glaucoma or prostatic hypertrophy [2]. Patients should be specifically warned about next-day sedation, which can persist for 12-24 hours after evening doses and significantly impair driving ability.

Serious adverse effects, whilst rare, include respiratory depression in young children, paradoxical excitation, and prolongation of the QT interval on ECG. The MHRA issued specific warnings about using promethazine in children under 2 years following reports of fatal respiratory depression, and it is now contraindicated in this age group [2]. Patients taking other medications that cause drowsiness or affect cardiac conduction require careful assessment before Phenergan can be prescribed.

Drug interactions represent another important consideration. Promethazine potentiates the effects of alcohol, benzodiazepines, opioids, and other central nervous system depressants. It can also interfere with allergy skin testing, as antihistamines suppress the wheal-and-flare response that allergists use to identify specific allergens. Patients should discontinue Phenergan at least 72 hours before scheduled allergy testing [3].

Contraindications and When to Avoid Phenergan

Phenergan syrup is contraindicated in children under 2 years, patients with acute asthma attacks, those who have taken monoamine oxidase inhibitors within the past 14 days, and patients with known hypersensitivity to phenothiazines. Caution is required in pregnancy, particularly in the third trimester, and breastfeeding mothers should avoid promethazine as it passes into breast milk and may cause sedation in infants [2].

Scientific References

1. Simons, F. E. R., & Simons, K. J. (2011). Histamine and H1-antihistamines: celebrating a century of progress. Journal of Allergy and Clinical Immunology, 128(6), 1139-1150. https://doi.org/10.1016/j.jaci.2011.09.005 [accessed 13 August 2026]
2. Medicines and Healthcare products Regulatory Agency. (2019). Promethazine hydrochloride: updated advice on use in children. Drug Safety Update, 12(9), 3-4. https://www.gov.uk/drug-safety-update/promethazine-hydrochloride-updated-advice-on-use-in-children [accessed 13 August 2026]
3. Church, M. K., & Church, D. S. (2013). Pharmacology of antihistamines. Indian Journal of Dermatology, 58(3), 219-224. https://doi.org/10.4103/0019-5154.110832 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2021). Insomnia: Clinical Knowledge Summary. NICE. https://cks.nice.org.uk/topics/insomnia/ [accessed 13 August 2026]
5. Holgate, S. T., Canonica, G. W., Simons, F. E., Taglialatela, M., Tharp, M., Timmerman, H., & Yanai, K. (2003). Consensus Group on New-Generation Antihistamines (CONGA): present status and recommendations. Clinical & Experimental Allergy, 33(9), 1305-1324. https://doi.org/10.1046/j.1365-2222.2003.01769.x [accessed 13 August 2026]
6. Weiner, J. M., Abramson, M. J., & Puy, R. M. (1998). Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ, 317(7173), 1624-1629. https://doi.org/10.1136/bmj.317.7173.1624 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.